Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sinovac Biotech Ltd.
SINOVAC Announces Decision to Declare Cash Dividend
Today 0:48 EDT
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Announces New Board Member and Chairman of the Audit Committee
March 28, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
February 28, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Issues Statement Regarding Privy Council Judgment
January 16, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2024 Financial Results
August 16, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
April 29, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 21, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
January 18, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
September 11, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
September 05, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
August 29, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Announces Change of Legal Representative of Sinovac Beijing
August 28, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2023 Financial Results
August 15, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
May 10, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
May 01, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2022 Financial Results
December 29, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Varicella Vaccine Prequalified by WHO
November 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC to Showcase Products at CPHI Frankfurt
October 28, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
September 06, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
August 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
July 19, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
July 14, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
July 04, 2022
From
SINOVAC Biotech Ltd.
Via
Business Wire
SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
June 25, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Polio Vaccine Prequalified by WHO
June 08, 2022
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
May 06, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
April 29, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
